Last update 08 May 2025

UAB Kelifarma

Private Company|Lithuania

Overview

Tags

Other Diseases
Skin and Musculoskeletal Diseases
Immune System Diseases
Mesenchymal stem cell therapy
CRISPR/Cas9
CAR-NK

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Mesenchymal stem cell therapy4
CRISPR/Cas91
Exosomes1
CAR-NK1

Related

7
Drugs associated with UAB Kelifarma
KELI-101
Target-
Mechanism-
Active Org.
UAB Kelifarma
Originator Org.
UAB Kelifarma
Active Indication
Acute Kidney Injury
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
KELI-102
Target-
Mechanism-
Active Org.
UAB Kelifarma
Originator Org.
UAB Kelifarma
Active Indication
Osteoarthritis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
KELI-104
Target-
Mechanism-
Active Org.
UAB Kelifarma
Originator Org.
UAB Kelifarma
Active Indication
Sweet Syndrome
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with UAB Kelifarma
NCT06678399
/ Not yet recruitingPhase 1/2
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
100 Clinical Results associated with UAB Kelifarma
Login to view more data
0 Patents (Medical) associated with UAB Kelifarma
Login to view more data
100 Deals associated with UAB Kelifarma
Login to view more data
100 Translational Medicine associated with UAB Kelifarma
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
3
Preclinical
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
KELI-101
Acute Kidney Injury
More
Phase 2 Clinical
KELI-102
Osteoarthritis
More
Preclinical
KELI-103
Respiratory Distress Syndrome, Acute
More
Preclinical
KELI-104
Sweet Syndrome
More
Preclinical
KELI-401
Solid tumor
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free